$ICL

ICL (ICL) Q2 2026 Earnings Call Transcript

ICL Group reported Q2 2026 sales of $2.1 billion, up 17%, and adjusted EBITDA of $448 million, up 28%, citing higher potash, bromine and phosphate prices. Adjusted net income rose 35% to $149 million, and adjusted EPS rose 33% to $0.12. Free cash flow was $94 million. Full-year 2026 EBITDA guidance was reiterated at $1.5 billion to $1.7 billion.

Original reporting
Published Aug 6, 2026, 3:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 3:58 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ICL (ICL) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ICLNeutralMed
01

Why it matters

The most tradable elements are the reiterated 2026 EBITDA range, quantified Elevate savings mix, and explicit margin risks from elevated sulfur and freight plus Brazil softness. These directly inform forward margin and cash-flow expectations.

02

Market read

Q2 profitability and cash flow improved, but management flagged continued second-half margin pressure from sulfur and freight, while maintaining the 2026 EBITDA outlook.

03

What to watch

The call emphasizes sulfur and freight risks, but also cites production efficiency gains and segment-specific EBITDA strength (notably Industrial Products). Traders may be underweighting the offsetting volume and pricing improvements versus raw-cost inflation.

Relevance 8/10Novelty 7/10Timing: pre-market today, Aug. 5 call transcript and guidance details

Background

ICL Group’s Q2 2026 earnings call covers segment performance, reiterated full-year EBITDA guidance, and a multiyear cost transformation program (Elevate) with reporting reorganization effective Q1 2027.

Company-level read

Ticker impact

$ICLNeutralMedium confidence
Context

ICL reported Q2 2026 sales of $2.1B, reiterated 2026 EBITDA guidance of $1.5B to $1.7B, and outlined the Elevate cost program through 2028.

Expected impact

Moderate volatility risk around margin expectations, with upside bias if sulfur/freight normalize and downside if they stay elevated.

Evidence & confidence

The call provides multiple decision-relevant datapoints: segment EBITDA growth, FCF improvement, leverage staying at 1.5x, and explicit risk commentary on sulfur and Brazil softness. However, the full-year EBITDA range is reiterated, limiting incremental surprise versus prior expectations.

Market effects

Fertilizer and industrial chemicals traders may reprice potash, phosphate, and bromine margin sensitivity to sulfur and freight, using ICL’s quantified headwinds.

Brazil softness commentary can influence sentiment for fertilizer demand and specialty fertilizer pricing in Brazil-linked exposures.

Freight disruption in the Middle East and currency (shekel vs USD) exposure highlight cross-border cost pressures relevant to global commodity supply chains.

Counterpoint

Elevate savings targets (productivity and SG&A optimization) could offset sulfur-driven margin pressure more than the market assumes, supporting a higher earnings floor than the risk framing implies.

Key entities

  • ICL Group Ltd

    Reported Q2 2026 results, reiterated 2026 EBITDA guidance, and detailed Elevate cost transformation and segment reorganization.

  • Elad Aharonson

    CEO who discussed functional food growth targets and ongoing margin risks (including Brazil softness).

  • Asaf Alperovitz

    CFO who quantified sulfur price dynamics and highlighted shekel exposure affecting Israel operations.

Related articles

$ICLMed

ICL reports Q2 2026 sales higher by 17% to $2.1 billion

ICL reported Q2 2026 sales of $2.1 billion, up 17% from $1.8 billion a year earlier, citing stronger pricing and demand. Operating income rose to $266 million from $181 million, and net income to $137 million from $93 million. Adjusted EBITDA was $448 million. ICL reiterated FY2026 adjusted EBITDA guidance of $1.5 billion to $1.7 billion and potash volumes of 4.5 to 4.7 million metric tons.

$ICLMedAI 8/10

ICL Group LTD: ICL Reports Second Quarter 2026 Results

ICL Group (NYSE: ICL) reported Q2 2026 results for the quarter ended June 30, 2026. Consolidated sales rose to $2.1 billion (+17% Y/Y). Operating income increased to $266 million from $181 million, and net income attributable to shareholders rose to $137 million from $93 million. ICL reiterated FY2026 adjusted EBITDA guidance of $1.5B to $1.7B and expects potash volumes of 4.5 to 4.7 million metric tons.

$FTNTHighAI 9/10

Fortinet (FTNT) Q2 2026 Earnings Call Transcript

Fortinet (FTNT) reported Q2 2026 results, saying billings rose 33% to $2.37 billion and total revenue increased 26% to $2.05 billion. Product revenue grew 52% to $773 million, and free cash flow more than tripled to nearly $1 billion. The company raised 2026 guidance, citing 34% SASE Firewall billings growth to over $2 billion and 25% AI-driven security ops billing growth.

$FTDRMed

Frontdoor, Inc. Q2 2026 Earnings Call Summary

Frontdoor, Inc. reported a Q2 2026 inflection with 1% total ending member growth and 5% direct-to-consumer growth, plus 7% real estate channel growth. Retention was 79.6% with 85% Autopay enrollment. Full-year 2026 revenue guidance was raised to $2.19B-$2.21B, and a $330M share buyback is expected to finish by end-2026. Weather may reverse a $5M benefit in Q3.

$QNSTHighAI 9/10

Why QuinStreet Stock Crushed it on Friday

QuinStreet (NASDAQ: QNST) reported fiscal Q4 and full-year 2026 results after market close Thursday. Q4 revenue rose 43% to $373.9 million, above an analyst estimate of just under $360 million. Net income nearly doubled to about $29 million, or $0.50/share. The company guided 2027 revenue to $1.45B-$1.55B, above $1.28B consensus.

$VNTMed

Vontier Corporation Q2 2026 Earnings Call Summary

Vontier’s Q2 2026 earnings call said Environmental & Fueling Solutions demand for dispensers and aftermarket parts drove results, while margin rose on VBS simplification (32 to 8 dispenser platforms, 1,400 SKUs). Full-year EPS guidance was raised, aided by accelerated share repurchases and tariff refunds. The EKOS acquisition targets $15m to $17m revenue by FY2027 and double-digit ROIC by year 3.